5.11
+0.23(+4.71%)
Currency In USD
| Previous Close | 4.88 |
| Open | 4.86 |
| Day High | 5.21 |
| Day Low | 4.85 |
| 52-Week High | 10.8 |
| 52-Week Low | 3.25 |
| Volume | 45,287 |
| Average Volume | 42,790 |
| Market Cap | 67.77M |
| PE | -1.65 |
| EPS | -3.1 |
| Moving Average 50 Days | 5.21 |
| Moving Average 200 Days | 5.56 |
| Change | 0.23 |
If you invested $1000 in INNOVATE Corp. (VATE) 10 years ago, it would be worth $3,500 as of January 18, 2025 at a share price of $5.11. Whereas If you bought $1000 worth of INNOVATE Corp. (VATE) shares 5 years ago, it would be worth $8,119.49 as of January 18, 2025 at a share price of $5.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
GlobeNewswire Inc.
5 hours ago
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe transdermal GFR (tGFR) methodology has been designed to be effective across the adult popul
INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands
GlobeNewswire Inc.
Nov 20, 2024 1:22 PM GMT
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced tod
INNOVATE Corp. Announces Third Quarter 2024 Results
GlobeNewswire Inc.
Nov 06, 2024 9:03 PM GMT
- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter -- Spectrum: Broadcasting's delivered another quarter of strong growth driven by network